Home  »  Trending   »  Here’s Our Rant About ImmunityBio Inc. (IBRX...

Here’s Our Rant About ImmunityBio Inc. (IBRX)

ImmunityBio Inc. (NASDAQ:IBRX) went up by 1.23% from its latest closing price compared to the recent 1-year high of $10.88. The company’s stock price has collected -23.02% of loss in the last five trading sessions.

Is It Worth Investing in ImmunityBio Inc. (NASDAQ :IBRX) Right Now?

Plus, the 36-month beta value for IBRX is at 1.63.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


IBRX currently public float of 83.44M and currently shorts hold a 24.20% ratio of that float. Today, the average trading volume of IBRX was 1.61M shares.

IBRX’s Market Performance

IBRX stocks went down by -23.02% for the week, with a monthly jump of 26.92% and a quarterly performance of 25.63%, while its annual performance rate touched -51.09%. The volatility ratio for the week stands at 11.24% while the volatility levels for the past 30 days are set at 10.69% for ImmunityBio Inc. The simple moving average for the period of the last 20 days is 2.01% for IBRX stocks with a simple moving average of -1.37% for the last 200 days.

Analysts’ Opinion of IBRX

Many brokerage firms have already submitted their reports for IBRX stocks, with Jefferies repeating the rating for IBRX by listing it as a “Buy.” The predicted price for IBRX in the upcoming period, according to Jefferies is $8 based on the research report published on August 03rd of the current year 2022.

IBRX Trading at 9.79% from the 50-Day Moving Average

After a stumble in the market that brought IBRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.50% of loss for the given period.

Volatility was left at 10.69%, however, over the last 30 days, the volatility rate increased by 11.24%, as shares surge +18.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.08% upper at present.

During the last 5 trading sessions, IBRX fell by -23.02%, which changed the moving average for the period of 200-days by -13.01% in comparison to the 20-day moving average, which settled at $4.89. In addition, ImmunityBio Inc. saw -18.59% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at IBRX starting from Adcock Richard, who purchase 1,930 shares at the price of $8.81 back on Oct 08. After this action, Adcock Richard now owns 1,930 shares of ImmunityBio Inc., valued at $16,995 using the latest closing price.

Stock Fundamentals for IBRX

Current profitability levels for the company are sitting at:

  • -35361.88 for the present operating margin

The net margin for ImmunityBio Inc. stands at -37129.55. Equity return is now at value 126.90, with -108.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.

Can Denbury Inc. (DEN) Remain Competitive?

Denbury Inc. (NYSE:DEN) went up by 2.28% from its latest closing price compared to the recent 1-year high of $93.95. The company’s stock price has